Learn more

T CELL SCIENCES INC

Overview
  • Total Patents
    123
About

T CELL SCIENCES INC has a total of 123 patent applications. Its first patent ever was published in 1985. It filed its patents most often in United States, WIPO (World Intellectual Property Organization) and Australia. Its main competitors in its focus markets pharmaceuticals, biotechnology and measurement are VALIRX PLC, TRION FORSKNING & UTVECKLING and MEDICAL BIOLOGY INST.

Patent filings per year

Chart showing T CELL SCIENCES INCs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Ip Stephen H 46
#2 Kung Patrick C 36
#3 Brenner Michael B 21
#4 Seidman Jonathan 19
#5 Marsh Henry C Jr 16
#6 Rittershaus Charles W 16
#7 Krangel Michael S 15
#8 Strominger Jack L 15
#9 Makrides Savvas C 12
#10 Bradbury Barton J 11

Latest patents

Publication Filing date Title
KR0133544B1 Human , , t cell antigen receptor polypeptides and nucleic
US5976540A Compositions comprising complement related proteins and carbohydrates, and methods for producing and using said compositions
AU2994997A Aptamers for complement protein c3b
WO9740022A1 Immunosuppressive compounds from an arylidene diamide array
WO9739722A2 Method of isolating regulators of t cell activation
CN1155903A T cell antigen receptor V region proteins and methods of preparation thereof
US5856300A Compositions comprising complement related proteins and carbohydrates, and methods for producing and using said compositions
WO9426786A1 Compositions comprising complement related proteins and carbohydrates, and methods for producing and using said compositions
WO9417822A1 PULMONARY ADMINISTRATION OF sCR1 AND OTHER COMPLEMENT INHIBITORY PROTEINS
US5552300A T cell antigen receptor V region proteins and methods of preparation thereof
GB9325182D0 Humanized antibodies or binding proteins thereof specific for t cell subpopulations exhibiting select beta chain variable regions
WO9414067A1 Diagnosis and therapy of sarcoidosis
US5456909A Glycoform fractions of recombinant soluble complement receptor 1 (sCR1) having extended half-lives in vivo
US5506247A Compounds that inhibit complement and/or suppress immune activity
CA2097825A1 Synergistic compositions of soluble complement receptors and compounds that inhibit complement and/or suppress immune activity
US5366986A Compounds which inhibit complement and/or suppress immune activity
IL108741A Monoclonal antibodies reactive with defined regions of the t cell antigen receptor
US5223426A Monoclonal antibodies reactive with defined regions of the t-cell antigen receptor
CA2005121A1 Monoclonal antibodies reactive with defined regions of the t cell antigen receptor
AU4416189A Therapeutic and diagnostic methods using soluble t cell surface molecules